Jian O Chen

US Patent:

7073830, Jul 11, 2006

Filed:

Oct 25, 2005

Appl. No.:

11/258303

Inventors:

Jian Chen - Flushing NY, US
Dennis Q. Chen - Flushing NY, US

International Classification:

B60R 19/44

US Classification:

293142, 293109, 293126

Abstract:

A bumper protection device for automobile bumpers to shield the bumpers from impact attaches to the automobile by a fabric shroud which attaches around the hood and trunk latch and suspends an impact resisting padded guard portion, adapted to the vehicle bumper, covering the entire front or rear bumper, the padded guard portion being drawn partially around the sides of the bumper and anchored by at least one elastic strap attached to opposing ends of the bumper guard portion, each elastic strap being further attached to the tires or wheel wells of the automobile retaining the bumper protection device over the entire rear bumper surface and around the sides of the bumper.

US Patent:

7572618, Aug 11, 2009

Filed:

Jun 28, 2007

Appl. No.:

11/824461

Inventors:

Gabriel A. Mintier - Hightstown NJ, US
Jian Chen - Princeton NJ, US
Bowman Miao - Churchville PA, US
Rex Arnold Parker - Titusville NJ, US

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

C12N 9/50
C12N 9/00
C12N 1/20
C12N 15/00
C07H 21/02
C07H 21/04

US Classification:

435219, 435183, 4352523, 4353201, 536 231, 536 232

Abstract:

The present invention provides novel polynucleotides encoding PCSK9b and PCSK9c polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel PCSK9b and PCSK9c polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

US Patent:

7767418, Aug 3, 2010

Filed:

May 15, 2008

Appl. No.:

12/152547

Inventors:

Ning Lee - Hillsborough NJ, US
Jian Chen - Princeton NJ, US
John N. Feder - Belle Mead NJ, US
Shujian Wu - Langhorne PA, US
Liana M. Lee - San Francisco CA, US
Michael A. Blanar - Malvern PA, US

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

C12P 21/06
C12N 15/00
C07K 1/00
C07H 21/02

US Classification:

435 691, 536 231, 536 236, 4353201, 530350

Abstract:

The present invention provides novel polynucleotides encoding LTRPC3 polypeptides, fragments and homologues thereof. The present invention also provides polynucleotides encoding variants and splice variants of LTRPC3 polypeptides, LTRPC3b, LTRPC3c, LTRPC3d, LTRPC3e, and LTRPC3f, respectively. Also provided are vectors, host cells, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel LTRPC3, LTRPC3b, LTRPC3c, LTRPC3d, LTRPC3e, and LTRPC3f polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

US Patent:

7846706, Dec 7, 2010

Filed:

Jun 23, 2009

Appl. No.:

12/456798

Inventors:

Gabriel A. Mintier - Hightstown NJ, US
Jian Chen - Princeton NJ, US
John N. Feder - Belle Mead NJ, US
Bowman Miao - Churchville PA, US
Rex Arnold Parker - Titusville NJ, US

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

C12N 9/00
C12N 9/50
C12N 1/20
C12N 15/00
C07H 21/02
C07H 21/04

US Classification:

435219, 435183, 4352523, 4353201, 536 231, 536 232

Abstract:

The present invention provides novel polynucleotides encoding PCSK9b and PCSK9c polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel PCSK9b and PCSK9c polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

US Patent:

8105804, Jan 31, 2012

Filed:

Oct 13, 2010

Appl. No.:

12/903658

Inventors:

Gabriel A. Mintier - Hightstown NJ, US
Jian Chen - Princeton NJ, US
John N. Feder - Belle Mead NJ, US
Bowman Miao - Churchville PA, US
Rex Arnold Parker - Titusville NJ, US

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

C12P 21/06
C12N 9/00
C12N 9/50
C12N 1/20
C12N 15/00
C07H 21/04

US Classification:

435 691, 435183, 435219, 4352523, 4353201, 536 231, 536 232

Abstract:

The present invention provides novel polynucleotides encoding PCSK9b and PCSK9c polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel PCSK9b and PCSK9c polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

US Patent:

8354264, Jan 15, 2013

Filed:

Dec 23, 2011

Appl. No.:

13/336371

Inventors:

Gabriel A. Mintier - Hightstown NJ, US
Jian Chen - Princeton NJ, US
John N. Feder - Belle Mead NJ, US
Bowman Miao - Churchville PA, US
Rex Arnold Parker - Titusville NJ, US

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

C12N 9/00
C12N 9/50
C12N 1/20
C12N 15/00
C07H 21/02
C07H 21/04

US Classification:

435219, 435183, 4352523, 4353201, 536 231, 536 232

Abstract:

The present invention provides novel polynucleotides encoding PCSK9b and PCSK9c polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel PCSK9b and PCSK9c polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

US Patent:

20040033506, Feb 19, 2004

Filed:

Dec 2, 2002

Appl. No.:

10/308128

Inventors:

Dennis Farrelly - Monmouth Junction NJ, US
Jian Chen - Princeton NJ, US
Thomas Nelson - Lawrenceville NJ, US
John Feder - Belle Mead NJ, US
Shujian Wu - Langhorne PA, US
Donna Bassolino - Hamilton NJ, US
Stanley Krystek - Ringoes NJ, US

International Classification:

C12Q001/68
C07H021/04
C12N009/10
C12P021/02
C12N005/06

US Classification:

435/006000, 435/069100, 435/193000, 435/320100, 435/325000, 536/023200

Abstract:

The present invention provides novel polynucleotides encoding Mitochondrial GPAT, Microsomal GPAT_hlog1, Microsomal GPAT_hlog2, Microsomal GPAT_hlog3, and/or Microsomal GPAT_hlog3_v1 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel Mitochondrial GPAT, Microsomal GPAT_hlog1, Microsomal GPAT_hlog2, Microsomal GPAT_hlog3, and/or Microsomal GPAT_hlog3_v1 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

US Patent:

20100167512, Jul 1, 2010

Filed:

Mar 9, 2010

Appl. No.:

12/720125

Inventors:

Yaoling Pan - East Windsor NJ, US
Jian Chen - Sunnyvale CA, US
Francisco Leon - Palo Alto CA, US
Shahriar Mostarshed - San Mateo CA, US
Linda T. Romano - Sunnyvale CA, US
Vijendra Sahi - Menlo Park CA, US
David P. Stumbo - Belmont CA, US

Assignee:

NANOSYS, INC. - Palo Alto CA

International Classification:

H01L 21/22

US Classification:

438549, 257E21135, 977762

Abstract:

Methods of doping nanostructures, such as nanowires, are disclosed. The methods provide a variety of approaches for improving existing methods of doping nanostructures. The embodiments include the use of a sacrificial layer to promote uniform dopant distribution within a nanostructure during post-nanostructure synthesis doping. In another embodiment, a high temperature environment is used to anneal nanostructure damage when high energy ion implantation is used. In another embodiment rapid thermal annealing is used to drive dopants from a dopant layer on a nanostructure into the nanostructure. In another embodiment a method for doping nanowires on a plastic substrate is provided that includes depositing a dielectric stack on a plastic substrate to protect the plastic substrate from damage during the doping process. An embodiment is also provided that includes selectively using high concentrations of dopant materials at various times in synthesizing nanostructures to realize novel crystallographic structures within the resulting nanostructure.

Address:

4010 Parsons Blvd APT 4A, Flushing, NY 11354

Phone:

9176508880

VIN:

5TDDK3EHXBS077406

Make:

TOYOTA

Model:

HIGHLANDER

Year:

2011